https://www.thebodypro.com/article/dolutegravir-based-two-drug-regimen-just-as-good-f
Dolutegravir (Tivicay)

Dolutegravir-Based Two-Drug Regimen Just as Good for HIV Treatment as Three-Drug Therapy, Study Says

    Barbara Jungwirth

    Barbara Jungwirth

    @bjungwirthNY

    Barbara Jungwirth is an experienced freelance journalist, writer, and translator who has been reporting on HIV for TheBody and TheBodyPro since 2002.